Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) Stock Forecast: StockMap's 2-Week Call

BDRX stock forecast: StockMap's model leans Underperform on Biodexa Pharmaceuticals plc American Depositary Shs for the two weeks after the Nov 13 close, toward BDRX trailing the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 5 of 6 two-week windows on BDRX since Aug 21; by chance, a call on the same dates was right 62% of the time.

Biodexa Pharmaceuticals plc American Depositary Shs last closed at $2.40, +0.84% on the session.

Against the IVW growth benchmark the position is +1.75% over the forecast window.

Biodexa Pharmaceuticals plc American Depositary Shs' market cap is $1.26M as of November 13, 2026.

Leans down ↘: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -39 (too close to call).

Where BDRX sits: sized by market cap, coloured by the day's move.

The read is built from 11 underlying insights — 0 bullish and 11 bearish.

Agreement across those insights is 100%.

45 daily calls for BDRX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

Biodexa Pharmaceuticals plc American Depositary Shs is classified under Health Care / Biotechnology.

StockMap tracks Biodexa Pharmaceuticals plc American Depositary Shs as the 387th largest of the 391 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 186 Moderate Underperform, 157 Neutral, 33 Strong Underperform and 15 Moderate Outperform.

On that composite Biodexa Pharmaceuticals plc American Depositary Shs ranks 291st of 391 in the group, against a group median of -0.24.

Other Health Care stocks

Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 13, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.

Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) — StockMap 2-week forecast & tracked accuracy